Abstract

SGC-GAK-1 (1) is a potent, selective, cell-active chemical probe for cyclin G-associated kinase (GAK). However, 1 was rapidly metabolized in mouse liver microsomes by cytochrome P450-mediated oxidation, displaying rapid clearance in liver microsomes and in mice, which limited its utility in in vivo studies. Chemical modifications of 1 that improved metabolic stability, generally resulted in decreased GAK potency. The best analog in terms of GAK activity in cells was 6-bromo-N-(1H-indazol-6-yl)quinolin-4-amine (35) (IC50 = 1.4 μM), showing improved stability in liver microsomes while still maintaining a narrow spectrum activity across the kinome. As an alternative to scaffold modifications we also explored the use of the broad-spectrum cytochrome P450 inhibitor 1-aminobenzotriazole (ABT) to decrease intrinsic clearance of aminoquinoline GAK inhibitors. Taken together, these approaches point towards the development of an in vivo chemical probe for the dark kinase GAK.

Highlights

  • IntroductionCyclin G-associated kinase (GAK) is a 160 kDa member of the numb-associated kinase (NAK)

  • Cyclin G-associated kinase (GAK) is a 160 kDa member of the numb-associated kinase (NAK)family of serine/threonine kinases [1]

  • We describe our efforts in the optimization of 4-aminoquinolines as potential in vivo chemical probes for GAK

Read more

Summary

Introduction

Cyclin G-associated kinase (GAK) is a 160 kDa member of the numb-associated kinase (NAK). Family of serine/threonine kinases [1]. GAK was originally identified as a directly associated partner of cyclin G, and is ubiquitously expressed across tissues [2]. Cytoplasm, and nucleus [3]. GAK has been genetically associated with a diverse range of biological processes. Genome-wide association studies have identified single nucleotide. Molecules 2019, 24, 4016 of biological processes. Genome-wide association studies have identified single nucleotide polymorphisms thatare areassociated associated with susceptibility to Parkinson’s [4].down

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call